BACKGROUND: Parathyroidectomy under nerve monitoring has been carried out for nearly ten years in the China-Japan Union Hospital of Jilin University. We retrospectively evaluated patients' prognosis with secondary hyperparathyroidism (SH) under neuro- and non-neuro-monitored parathyroidectomy anesthesia. The purpose of this study is to summarize and introduce a new anesthesia scheme for parathyroidectomy under nerve monitoring. METHODS: From January 2000 to December 2019, 200 patients with SH in the China-Japan Union Hospital of Jilin University were retrospectively analyzed. Among them, 100 patients underwent parathyroidectomy under neurological monitoring (Group A), and 100 patients underwent parathyroidectomy without neurological monitoring (Group B). The dosage of muscle relaxant, parathyroid hormone (PTH), serum calcium, phosphorus, urea, creatinine, and alkaline phosphatase (ALP) was recorded before surgery (T0), after surgery (T1), at discharge (T2), during skin incision (Ta), at four parathyroidectomies (Tb), and 10 min after total removal. The levels of PTH were measured at four-time points (Tc) and 30 minutes (Td) after complete resection. RESULTS: After screening and propensity score match (PSM), the data of 92 patients were analyzed. Group A's muscle relaxant dose was significantly less than Group B; the length of hospital stay in Group A was significantly lower than in Group B (P<0.05). The serum calcium levels, phosphorus, urea, and creatinine at T2 in Group A were lower than those in Group B (P<0.05). CONCLUSIONS: Parathyroid nerve monitoring technology combined with preoperative complete anesthesia scheme, anesthesia induction with one time ED95 (95% effective drug dose) cis-atracurium, end breath gas, and sevoflurane maintenance anesthesia under BIS monitoring can improve the prognosis of patients, shorten the length of hospital stay, and is effective and safe. 2021 Gland Surgery. All rights reserved.
BACKGROUND: Parathyroidectomy under nerve monitoring has been carried out for nearly ten years in the China-Japan Union Hospital of Jilin University. We retrospectively evaluated patients' prognosis with secondary hyperparathyroidism (SH) under neuro- and non-neuro-monitored parathyroidectomy anesthesia. The purpose of this study is to summarize and introduce a new anesthesia scheme for parathyroidectomy under nerve monitoring. METHODS: From January 2000 to December 2019, 200 patients with SH in the China-Japan Union Hospital of Jilin University were retrospectively analyzed. Among them, 100 patients underwent parathyroidectomy under neurological monitoring (Group A), and 100 patients underwent parathyroidectomy without neurological monitoring (Group B). The dosage of muscle relaxant, parathyroid hormone (PTH), serum calcium, phosphorus, urea, creatinine, and alkaline phosphatase (ALP) was recorded before surgery (T0), after surgery (T1), at discharge (T2), during skin incision (Ta), at four parathyroidectomies (Tb), and 10 min after total removal. The levels of PTH were measured at four-time points (Tc) and 30 minutes (Td) after complete resection. RESULTS: After screening and propensity score match (PSM), the data of 92 patients were analyzed. Group A's muscle relaxant dose was significantly less than Group B; the length of hospital stay in Group A was significantly lower than in Group B (P<0.05). The serum calcium levels, phosphorus, urea, and creatinine at T2 in Group A were lower than those in Group B (P<0.05). CONCLUSIONS: Parathyroid nerve monitoring technology combined with preoperative complete anesthesia scheme, anesthesia induction with one time ED95 (95% effective drug dose) cis-atracurium, end breath gas, and sevoflurane maintenance anesthesia under BIS monitoring can improve the prognosis of patients, shorten the length of hospital stay, and is effective and safe. 2021 Gland Surgery. All rights reserved.
Authors: Gregory W Randolph; Henning Dralle; Hisham Abdullah; Marcin Barczynski; Rocco Bellantone; Michael Brauckhoff; Bruno Carnaille; Sergii Cherenko; Fen-Yu Chiang; Gianlorenzo Dionigi; Camille Finck; Dana Hartl; Dipti Kamani; Kerstin Lorenz; Paolo Miccolli; Radu Mihai; Akira Miyauchi; Lisa Orloff; Nancy Perrier; Manuel Duran Poveda; Anatoly Romanchishen; Jonathan Serpell; Antonio Sitges-Serra; Tod Sloan; Sam Van Slycke; Samuel Snyder; Hiroshi Takami; Erivelto Volpi; Gayle Woodson Journal: Laryngoscope Date: 2011-01 Impact factor: 3.325
Authors: Erdal Tunç; Osman Demirhan; Yahya Sağliker; İsmail Yildiz; Nuray Paylar; Ali İrfan Güzel Journal: Turk J Med Sci Date: 2017-02-27 Impact factor: 0.973
Authors: Brandon Michael Henry; Matthew J Graves; Jens Vikse; Beatrice Sanna; Przemysław A Pękala; Jerzy A Walocha; Marcin Barczyński; Krzysztof A Tomaszewski Journal: Langenbecks Arch Surg Date: 2017-04-04 Impact factor: 3.445